2710
T. Yang et al. / Tetrahedron 72 (2016) 2707e2711
determined by HPLC (Chiralpak AD-H, hexane/2-propanol¼95/5,
.0 mL/min, 254 nm). T
¼6.03 min, 7.13 min (major).
d
197.8, 163.4,144.8,130.4,130.3,128.4,127.7,126.2,113.7, 55.5, 45.3,
þ
1
R
43.2, 29.2, 12.1; HRMS-ESI (m/z): calcd for C18
20
H O
2
(MþNa ):
2
91.1356, found 291.1352. The enantiomeric excess was determined
by HPLC (Chiralpak AD-H, hexane/2-propanol¼95/5, 1.0 mL/min,
254 nm). T
¼12.89 min, 20.21 min (major).
4.4.5. 3-(4-Chlorophenyl)-1-phenyl-pentanone
(2e). 1
H
NMR
(
7
400 MHz, CDCl 7.88 (d, J¼7.4 Hz 2H), 7.56e7.51 (m, 1H),
.45e7.40 (m, 2H), 7.26e7.23 (m, 2H), 7.17e7.14 (m, 2H), 3.26e3.20
m, 3H),1.82e1.73 (m, 1H), 1.65e1.58 (m, 1H), 0.80 (t, J¼7.3 Hz, 3H);
3
)
d
R
(
4.4.12. 1-(4-Chlorophenyl)-3-phenyl-1-pentanone (2l). 1
(400 MHz, CDCl 7.83e7.80 (m, 2H), 7.40e7.37 (m, 2H), 7.30e7.25
(m, 2H), 7.22e7.15 (m, 3H), 3.27e3.17 (m, 3H), 1.81e1.73 (m, 1H),
H
NMR
1
3
C NMR (100 MHz, CDCl
3
)
d
198.8, 143.2, 137.2, 133.0, 131.9, 129.0,
3
) d
1
C
28.6, 128.5, 128.0, 45.4, 42.4, 29.3, 12.0; HRMS-ESI (m/z): calcd for
þ
13
17
H17ClO (MþNa ): 295.0860, found 295.0854. The enantiomeric
1.68e1.60 (m, 1H), 0.80 (t, J¼7.4 Hz, 3H); C NMR (100 MHz, CDCl
3
)
excess was determined by HPLC (Chiralpak AD-H, hexane/2-
d
198.0, 144.4, 139.3, 135.6, 129.5, 128.8, 128.5, 127.6, 45.6, 43.1, 29.2,
þ
propanol¼95/5,1.0 mL/min, 254 nm). T
R
¼5.94 min (S), 8.08 min (R).
12.1; HRMS-ESI (m/z): calcd for C17
found 295.0850. The enantiomeric excess was determined by HPLC
H
17ClO (MþNa ): 295.0860,
4.4.6. 3-(4-Fluorophenyl)-1-phenyl-pentanone
(2f). 1
H
NMR
(Chiralpak AD-H, hexane/2-propanol¼95/5, 1.0 mL/min, 254 nm).
(
400 MHz, CDCl 7.90e7.87 (m, 2H),7.56e7.51 (m, 1H), 7.45e7.41
3
)
d
T
R
¼7.03 min, 8.74 min (major).
(
3
m, 2H), 7.20e7.15 (m, 2H), 6.99e6.93 (m, 2H), 3.28e3.20 (m,
13
4.4.13. 1-(4-Bromophenyl)-3-phenyl-1-pentanone (2m). 1
(400 MHz, CDCl 7.76e7.73 (m, 2H), 7.57e7.54 (m, 2H), 7.30e7.25
(m, 2H), 7.22e7.15 (m, 3H), 3.26e3.17 (m, 3H), 1.81e1.74 (m, 1H),
H),1.81e1.74 (m, 1H), 1.63e1.60 (m, 1H), 0.80 (t, J¼7.3 Hz, 3H);
C
H NMR
NMR (100 MHz, CDCl
3
)
d
199.1, 161.4 (J¼242.3 Hz), 140.3 (J¼3.2 Hz),
3
) d
1
4
2
37.2, 133.0, 129.0 (J¼7.7 Hz), 128.7, 128.0, 115.2 (J¼20.9 Hz), 45.7,
þ
13
2.3, 29.4, 12.0; HRMS-ESI (m/z): calcd for C17
H17FO (MþNa ):
1.68e1.60 (m, 1H), 0.81 (t, J¼7.3 Hz, 3H); C NMR (100 MHz, CDCl
3
)
79.1156, found 279.1156. The enantiomeric excess was determined
d
198.2,144.4,136.0,131.8, 129.6,128.5,128.1, 127.6, 126.4, 45.6, 43.1,
þ
by HPLC (Chiralpak AD-H, hexane/2-propanol¼95/5, 1.0 mL/min,
29.2, 12.1; HRMS-ESI (m/z): calcd for
339.0355, found 339.0350. The enantiomeric excess was de-
C
17
H
17BrO (MþNa ):
2
54 nm). T
R
¼6.18 min, 7.79 min (major).
termined by HPLC (Chiralpak AD-H, hexane/2-propanol¼95/5,
4
.4.7. 4-Phenyl-2-hexanone (2g). 1
H
NMR (400 MHz, CDCl
3
)
1.0 mL/min, 254 nm). T
R
¼7.56 min, 9.38 min (major);
d
7.33e7.28 (m, 3H), 7.23e7.19 (m, 2H), 3.09e3.02 (m, 1H), 2.75 (d,
J¼7.1 Hz, 2H), 2.04 (s, 3H), 1.74e1.55 (m, 2H), 0.80 (t, J¼7.3 Hz, 3H);
4.4.14. 1,3,5-Triphenyl-2-(1-phenylpropyl)pentane-1,5-dione (4). 1
NMR (300 MHz, CDCl 7.76e7.73 (m, 2H), 7.65e7.62 (m, 2H),
7.47e7.35 (m, 1H), 7.35e7.26 (m, 10H), 7.09e7.07 (m, 3H),
6.92e6.90 (m, 2H), 4.54e4.49 (m, 1H), 3.81e3.79 (m, 1H),
3.32e3.24 (m, 1H), 3.14e3.12 (m, 1H), 3.08e3.00 (m, 1H), 1.69e1.65
H
1
3
C NMR (100 MHz, CDCl
3
)
d
208.1, 144.3, 128.5, 127.6, 126.4, 50.6,
3
) d
þ
4
1
3.0, 30.7, 29.4, 12.0; HRMS-ESI (m/z): calcd for C12
99.1093, found 199.1094. The enantiomeric excess was de-
H16O (MþNa ):
termined by HPLC (Chiralcel OJ-H, hexane/2-propanol¼95/5,
13
0
.8 mL/min, 254 nm). T
R
¼10.75 min (S), 11.94 min (R).
(m, 1H), 1.56e1.52 (m, 1H), 0.61 (t, J¼7.3 Hz, 3H); C NMR (75 MHz,
CDCl 203.5, 198.6, 142.2, 141.0, 139.8, 136.8, 132.8, 132.5, 129.0,
3
) d
4
.4.8. 5-Phenyl-3-heptanone (2h). 1
H
NMR (400 MHz, CDCl
3
)
128.4, 128.33, 128.31, 127.9, 127.7, 126.5, 54.2, 48.5, 42.5, 41.6, 27.1,
11.9; HRMS-ESI (m/z): calcd for C32
found 469.2139.
þ
d
7.31e7.29 (m, 3H), 7.20e7.18 (m, 2H), 3.11e3.03 (m,1H), 2.73e2.71
H
30
O
2
(MþNa ): 469.2138,
(
0
1
m, 2H), 2.40e2.19 (m, 2H), 1.73e1.55 (m, 2H), 0.97 (t, J¼7.3 Hz, 3H),
13
.80 (t, J¼7.3 Hz, 3H); C NMR (100 MHz, CDCl
3
) d 210.7, 144.5,
28.4, 127.6, 126.3, 49.4, 43.0, 36.7, 29.3, 12.0, 7.6; HRMS-ESI (m/z):
4.4.15. 2-(2-Benzoyl-3-ethylcyclohexyl)-1-phenylethanone (6). 1
NMR (300 MHz, CDCl 8.05e8.01 (m, 2H), 7.78e7.77 (m, 2H),
H
þ
calcd for C13
H
18O (MþNa ): 213.1250, found213.1251. The enan-
3
) d
tiomeric excess was determined by HPLC (Chiralpak AD-H, hexane/
7.57e7.26 (m, 6H), 3.19 (t, J¼5.1 Hz, 1H), 2.89e2.85 (q, 1H),
2
6
-propanol¼95/5, 1.0 mL/min, 254 nm). T ¼5.75 min (major),
R
2.48e2.44 (m, 2H), 1.79e1.74 (m, 1H), 1.73e1.62 (m, 3H), 1.27e1.22
13
.57 min.
(m, 4H), 1.05e0.99 (m, 2H), 0.77 (t, J¼7.4 Hz, 3H), C NMR
100 MHz, CDCl 206.6, 199.4, 139.4, 136.8, 133.3, 132.9, 128.8,
(
3
) d
4
CDCl
3
1
CDCl
.4.9. 4-(4-Methoxyphenyl)-2-hexanone (2i). 1H NMR (400 MHz,
7.12e7.10 (m, 2H), 6.86e6.84 (m, 2H), 3.80 (s, 3H),
.03e2.96 (m, 1H), 2.72e2.70 (m, 2H), 2.03 (s, 3H), 1.69e1.63 (m,
128.6, 128.2, 128.1, 44.2, 43.3, 38.8, 31.7, 30.5, 29.7, 27.7, 25.2, 11.2;
HRMS-ESI (m/z): calcd for C23
357.1815. The enantiomeric excess was determined by HPLC
þ
3
)
d
H
26
O
2
(MþNa ): 357.1825, found
13
H), 1.58e1.50 (m, 1H), 0.80 (t, J¼7.4 Hz, 3H); C NMR (100 MHz,
(Chiralpak AD-H, hexane/2-propanol¼95/5, 1.0 mL/min, 254 nm).
3
)
d
208.4, 158.0, 136.3, 128.4, 113.8, 55.2, 50.8, 42.3, 30.7, 29.5,
T
R
¼9.80 min (major), 10.53 min.
þ
12.0; HRMS-ESI (m/z): calcd for C13
H
18
O
2
(MþNa ): 229.1199,
found 229.1194. The enantiomeric excess was determined by HPLC
Chiralpak AD-H, hexane/2-propanol¼95/5, 1.0 mL/min, 254 nm).
¼6.05 min (major), 6.60 min.
Acknowledgements
(
T
R
We are grateful to the support of National Natural Science
Foundation of China (No. 21472184, 21572218, 21272226 and
2
of Technology (D. Li) and Western-Light Foundation of Chinese
Academy of Sciences (J. Liao).
4
.4.10. 4-(4-Chlorophenyl)-2-hexanone (2j). 1H NMR (300 MHz,
CDCl 7.30e7.26 (m, 2H), 7.15e7.10 (m, 2H), 3.07e3.02 (m, 1H),
.74e2.71 (m, 2H), 2.05 (s, 3H), 1.71e1.54 (m, 2H), 0.79 (t, J¼7.4 Hz,
1402186), the Hundred-Talent Program Fund of Hubei University
3
) d
2
3
5
13
3
H); C NMR (100 MHz, CDCl ) d 207.6, 142.8, 131.9, 128.9, 128.6,
0.4, 42.2, 30.7, 29.3, 11.9; HRMS-ESI (m/z): calcd for C12
H15ClO
Supplementary data
þ
(
MþNa ): 233.0704, found 233.0709. The enantiomeric excess was
determined by HPLC (Chiralpak AD-H, hexane/2-propanol¼95/5,
1
.0 mL/min, 254 nm). T
R
¼5.13 min (major), 5.50 min.
4
(
(
.4.11. 1-(4-Methoxyphenyl)-3-phenyl-1-pentanone (2k). 1H NMR
400 MHz, CDCl 7.90e7.88 (m, 2H), 7.26e7.15 (m, 5H), 6.90e9.88
m, 2H), 3.85 (s, 3H), 3.24e3.17 (m, 3H), 1.80e1.73 (m, 1H),
References and notes
3
) d
13
1.67e1.58 (m, 1H), 0.79 (t, J¼7.3 Hz, 3H); C NMR (100 MHz, CDCl
3
)